Search Results - "PACAK, KAREL"

Refine Results
  1. 1

    New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification by Crona, Joakim, Taïeb, David, Pacak, Karel

    Published in Endocrine reviews (01-12-2017)
    “…A molecular biology–based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically…”
    Get full text
    Journal Article
  2. 2

    Pheochromocytoma: The First Metabolic Endocrine Cancer by Jochmanova, Ivana, Pacak, Karel

    Published in Clinical cancer research (15-10-2016)
    “…Dysregulated metabolism is one of the key characteristics of cancer cells. The most prominent alterations are present during regulation of cell respiration,…”
    Get full text
    Journal Article
  3. 3

    Mitochondrial Complex II: At the Crossroads by Bezawork-Geleta, Ayenachew, Rohlena, Jakub, Dong, Lanfeng, Pacak, Karel, Neuzil, Jiri

    “…Mitochondrial complex II (CII), also called succinate dehydrogenase (SDH), is a central purveyor of the reprogramming of metabolic and respiratory adaptation…”
    Get full text
    Journal Article
  4. 4

    Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups by Taïeb, David, Jha, Abhishek, Treglia, Giorgio, Pacak, Karel

    Published in Endocrine-related cancer (01-11-2019)
    “…In recent years, advancement in genetics has profoundly helped to gain a more comprehensive molecular, pathogenic, and prognostic picture of pheochromocytomas…”
    Get full text
    Journal Article
  5. 5

    Personalized Management of Pheochromocytoma and Paraganglioma by Nölting, Svenja, Bechmann, Nicole, Taieb, David, Beuschlein, Felix, Fassnacht, Martin, Kroiss, Matthias, Eisenhofer, Graeme, Grossman, Ashley, Pacak, Karel

    Published in Endocrine reviews (01-04-2022)
    “…Abstract Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying…”
    Get full text
    Journal Article
  6. 6

    Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma by Ilanchezhian, Maran, Jha, Abhishek, Pacak, Karel, Del Rivero, Jaydira

    Published in Current treatment options in oncology (29-08-2020)
    “…Opinion statement The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and…”
    Get full text
    Journal Article
  7. 7

    Genomic Landscape of Pheochromocytoma and Paraganglioma by Jochmanova, Ivana, Pacak, Karel

    Published in Trends in cancer (01-01-2018)
    “…Recent comprehensive molecular analysis allowed the identification of unique molecular signatures in pheochromocytomas (PHEOs) and paragangliomas (PGLs). Here…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging by Alrezk, Rami, Suarez, Andres, Tena, Isabel, Pacak, Karel

    Published in Frontiers in endocrinology (Lausanne) (27-11-2018)
    “…Pheochromocytomas and paragangliomas (PCCs/PGLs) are rare commonly benign neuroendocrine tumors that share pathology features and clinical behavior in many…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Mapping of human brown adipose tissue in lean and obese young men by Leitner, Brooks P., Huang, Shan, Brychta, Robert J., Duckworth, Courtney J., Baskin, Alison S., McGehee, Suzanne, Tal, Ilan, Dieckmann, William, Gupta, Garima, Kolodny, Gerald M., Pacak, Karel, Herscovitch, Peter, Cypess, Aaron M., Chen, Kong Y.

    “…Human brown adipose tissue (BAT) can be activated to increase glucose uptake and energy expenditure, making it a potential target for treating obesity and…”
    Get full text
    Journal Article
  12. 12

    Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline by Lenders, Jacques W. M, Duh, Quan-Yang, Eisenhofer, Graeme, Gimenez-Roqueplo, Anne-Paule, Grebe, Stefan K. G, Murad, Mohammad Hassan, Naruse, Mitsuhide, Pacak, Karel, Young, William F

    “…Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL). Participants: The Task Force included a chair…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions by Deroose, Christophe M, Hindié, Elif, Kebebew, Electron, Goichot, Bernard, Pacak, Karel, Taïeb, David, Imperiale, Alessio

    Published in Journal of Nuclear Medicine (01-12-2016)
    “…Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroenteropancreatic neuroendocrine tumors…”
    Get full text
    Journal Article
  15. 15

    Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine by Nölting, Svenja, Ullrich, Martin, Pietzsch, Jens, Ziegler, Christian G., Eisenhofer, Graeme, Grossman, Ashley, Pacak, Karel

    Published in Cancers (08-10-2019)
    “…Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Genetic Determinants of Pheochromocytoma and Paraganglioma Imaging Phenotypes by Taïeb, David, Pacak, Karel

    Published in Journal of Nuclear Medicine (01-05-2020)
    “…Parallel to the application of new PET radiopharmaceuticals for pheochromocytoma and paraganglioma (collectively named PPGLs) imaging, several studies have…”
    Get full text
    Journal Article
  18. 18

    Phaeochromocytoma — advances through science, collaboration and spreading the word by Pacak, Karel, Eisenhofer, Graeme, Tischler, Arthur S.

    Published in Nature reviews. Endocrinology (01-11-2020)
    “…The first International Symposium on Phaeochromocytoma in 2005 was followed by considerable progress in the field, largely owing to the many collaborations and…”
    Get full text
    Journal Article
  19. 19

    Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia by Zhuang, Zhengping, Yang, Chunzhang, Lorenzo, Felipe, Merino, Maria, Fojo, Tito, Kebebew, Electron, Popovic, Vera, Stratakis, Constantine A, Prchal, Josef T, Pacak, Karel

    Published in The New England journal of medicine (06-09-2012)
    “…Two patients with paraganglioma (one of whom also had somatostatinoma) were found to have mutations in HIF2A that altered HIF-2α turnover and led to excess…”
    Get full text
    Journal Article
  20. 20

    Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans by Lee, Paul, Linderman, Joyce D., Smith, Sheila, Brychta, Robert J., Wang, Juan, Idelson, Christopher, Perron, Rachel M., Werner, Charlotte D., Phan, Giao Q., Kammula, Udai S., Kebebew, Electron, Pacak, Karel, Chen, Kong Y., Celi, Francesco S.

    Published in Cell metabolism (04-02-2014)
    “…Rediscovery of cold-activated brown adipose tissue (BAT) in humans has boosted research interest in identifying BAT activators for metabolic benefits. Of…”
    Get full text
    Journal Article